Literature DB >> 27120157

Molecular mechanism of APC/C activation by mitotic phosphorylation.

Suyang Zhang1, Leifu Chang1, Claudio Alfieri1, Ziguo Zhang1, Jing Yang1, Sarah Maslen1, Mark Skehel1, David Barford1.   

Abstract

In eukaryotes, the anaphase-promoting complex (APC/C, also known as the cyclosome) regulates the ubiquitin-dependent proteolysis of specific cell-cycle proteins to coordinate chromosome segregation in mitosis and entry into the G1 phase. The catalytic activity of the APC/C and its ability to specify the destruction of particular proteins at different phases of the cell cycle are controlled by its interaction with two structurally related coactivator subunits, Cdc20 and Cdh1. Coactivators recognize substrate degrons, and enhance the affinity of the APC/C for its cognate E2 (refs 4-6). During mitosis, cyclin-dependent kinase (Cdk) and polo-like kinase (Plk) control Cdc20- and Cdh1-mediated activation of the APC/C. Hyperphosphorylation of APC/C subunits, notably Apc1 and Apc3, is required for Cdc20 to activate the APC/C, whereas phosphorylation of Cdh1 prevents its association with the APC/C. Since both coactivators associate with the APC/C through their common C-box and Ile-Arg tail motifs, the mechanism underlying this differential regulation is unclear, as is the role of specific APC/C phosphorylation sites. Here, using cryo-electron microscopy and biochemical analysis, we define the molecular basis of how phosphorylation of human APC/C allows for its control by Cdc20. An auto-inhibitory segment of Apc1 acts as a molecular switch that in apo unphosphorylated APC/C interacts with the C-box binding site and obstructs engagement of Cdc20. Phosphorylation of the auto-inhibitory segment displaces it from the C-box-binding site. Efficient phosphorylation of the auto-inhibitory segment, and thus relief of auto-inhibition, requires the recruitment of Cdk-cyclin in complex with a Cdk regulatory subunit (Cks) to a hyperphosphorylated loop of Apc3. We also find that the small-molecule inhibitor, tosyl-l-arginine methyl ester, preferentially suppresses APC/C(Cdc20) rather than APC/C(Cdh1), and interacts with the binding sites of both the C-box and Ile-Arg tail motifs. Our results reveal the mechanism for the regulation of mitotic APC/C by phosphorylation and provide a rationale for the development of selective inhibitors of this state.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27120157      PMCID: PMC4878669          DOI: 10.1038/nature17973

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  45 in total

1.  Structural analysis of human Cdc20 supports multisite degron recognition by APC/C.

Authors:  Wei Tian; Bing Li; Ross Warrington; Diana R Tomchick; Hongtao Yu; Xuelian Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

2.  UCSF Chimera, MODELLER, and IMP: an integrated modeling system.

Authors:  Zheng Yang; Keren Lasker; Dina Schneidman-Duhovny; Ben Webb; Conrad C Huang; Eric F Pettersen; Thomas D Goddard; Elaine C Meng; Andrej Sali; Thomas E Ferrin
Journal:  J Struct Biol       Date:  2011-09-22       Impact factor: 2.867

3.  Activation of the APC/C ubiquitin ligase by enhanced E2 efficiency.

Authors:  Vanessa A Van Voorhis; David O Morgan
Journal:  Curr Biol       Date:  2014-06-12       Impact factor: 10.834

4.  Recombinant expression, reconstitution and structure of human anaphase-promoting complex (APC/C).

Authors:  Ziguo Zhang; Jing Yang; Eric H Kong; William C H Chao; Edward P Morris; Paula C A da Fonseca; David Barford
Journal:  Biochem J       Date:  2013-01-15       Impact factor: 3.857

5.  Systematic phosphorylation analysis of human mitotic protein complexes.

Authors:  Björn Hegemann; James R A Hutchins; Otto Hudecz; Maria Novatchkova; Jonathan Rameseder; Martina M Sykora; Sihan Liu; Michael Mazanek; Péter Lénárt; Jean-Karim Hériché; Ina Poser; Norbert Kraut; Anthony A Hyman; Michael B Yaffe; Karl Mechtler; Jan-Michael Peters
Journal:  Sci Signal       Date:  2011-11-08       Impact factor: 8.192

6.  Initiation of translation by cricket paralysis virus IRES requires its translocation in the ribosome.

Authors:  Israel S Fernández; Xiao-Chen Bai; Garib Murshudov; Sjors H W Scheres; V Ramakrishnan
Journal:  Cell       Date:  2014-05-01       Impact factor: 41.582

7.  Mad2 and the APC/C compete for the same site on Cdc20 to ensure proper chromosome segregation.

Authors:  Daisuke Izawa; Jonathon Pines
Journal:  J Cell Biol       Date:  2012-09-24       Impact factor: 10.539

8.  Ribosome structures to near-atomic resolution from thirty thousand cryo-EM particles.

Authors:  Xiao-Chen Bai; Israel S Fernandez; Greg McMullan; Sjors H W Scheres
Journal:  Elife       Date:  2013-02-19       Impact factor: 8.140

Review 9.  Panta rhei: the APC/C at steady state.

Authors:  Ivana Primorac; Andrea Musacchio
Journal:  J Cell Biol       Date:  2013-04-15       Impact factor: 10.539

10.  Electron counting and beam-induced motion correction enable near-atomic-resolution single-particle cryo-EM.

Authors:  Xueming Li; Paul Mooney; Shawn Zheng; Christopher R Booth; Michael B Braunfeld; Sander Gubbens; David A Agard; Yifan Cheng
Journal:  Nat Methods       Date:  2013-05-05       Impact factor: 28.547

View more
  89 in total

1.  Distinct kinetics of serine and threonine dephosphorylation are essential for mitosis.

Authors:  Jamin B Hein; Emil P T Hertz; Dimitriya H Garvanska; Thomas Kruse; Jakob Nilsson
Journal:  Nat Cell Biol       Date:  2017-10-30       Impact factor: 28.824

2.  Mitotic Exit Dysfunction through the Deregulation of APC/C Characterizes Cisplatin-Resistant State in Epithelial Ovarian Cancer.

Authors:  Anil Belur Nagaraj; Olga Kovalenko; Rita Avelar; Peronne Joseph; Annalyn Brown; Arshia Surti; Sandra Mantilla; Analisa DiFeo
Journal:  Clin Cancer Res       Date:  2018-04-13       Impact factor: 12.531

Review 3.  APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.

Authors:  Morgan S Schrock; Benjamin R Stromberg; Luke Scarberry; Matthew K Summers
Journal:  Semin Cancer Biol       Date:  2020-03-09       Impact factor: 15.707

4.  Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization.

Authors:  Hiroyuki Kato; Kaori Asamitsu; Wendi Sun; Shojiro Kitajima; Naoko Yoshizawa-Sugata; Takashi Okamoto; Hisao Masai; Lorenz Poellinger
Journal:  Oncogene       Date:  2020-02-18       Impact factor: 9.867

5.  The PP2AB56 phosphatase promotes the association of Cdc20 with APC/C in mitosis.

Authors:  Sun Joo Lee; Veronica Rodriguez-Bravo; Hyunjung Kim; Sutirtha Datta; Emily A Foley
Journal:  J Cell Sci       Date:  2017-04-12       Impact factor: 5.285

6.  Cell division: Mitotic regulation comes into focus.

Authors:  David O Morgan
Journal:  Nature       Date:  2016-08-10       Impact factor: 49.962

7.  Hematopoietic PBX-interacting protein is a substrate and an inhibitor of the APC/C-Cdc20 complex and regulates mitosis by stabilizing cyclin B1.

Authors:  Saratchandra Singh Khumukcham; Venkata Subramanyam Kumar Samanthapudi; Vasudevarao Penugurti; Anita Kumari; P S Kesavan; Loka Reddy Velatooru; Siva Reddy Kotla; Aprotim Mazumder; Bramanandam Manavathi
Journal:  J Biol Chem       Date:  2019-05-17       Impact factor: 5.157

8.  Identification of cancer driver genes based on nucleotide context.

Authors:  Felix Dietlein; Donate Weghorn; Amaro Taylor-Weiner; André Richters; Brendan Reardon; David Liu; Eric S Lander; Eliezer M Van Allen; Shamil R Sunyaev
Journal:  Nat Genet       Date:  2020-02-03       Impact factor: 38.330

9.  Structure of the super-elongation complex subunit AFF4 C-terminal homology domain reveals requirements for AFF homo- and heterodimerization.

Authors:  Ying Chen; Patrick Cramer
Journal:  J Biol Chem       Date:  2019-05-30       Impact factor: 5.157

Review 10.  Posing the APC/C E3 Ubiquitin Ligase to Orchestrate Cell Division.

Authors:  Edmond R Watson; Nicholas G Brown; Jan-Michael Peters; Holger Stark; Brenda A Schulman
Journal:  Trends Cell Biol       Date:  2018-10-25       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.